期刊文献+

宜昌市2006-2013年急性脑膜炎和脑炎病例流行病学分析

Epidemiological analysis of acute cerebral meningitis and encephalitis in Yichang city, 2006-2013
原文传递
导出
摘要 目的建立急性脑膜炎和脑炎(AMES)监测系统,了解其流行病学特征,为疾病防控和临床诊断治疗提供科学依据。方法在宜昌市选取6家监测医院,开展急性脑膜炎和脑炎相关疾病的流行病学调查。结果 2006-2013年宜昌市城区AMES病例占54.7%(1 385/2 532),发病高峰季节出现在5-7月,病例以学生、农民居多,治愈好转率为93.8%(2 374/2 532);病毒性感染占51.9%(1 313/2 532),细菌性感染占15.5%(393/2 532),病因未明病例占26.9%(682/2532)。结论监测系统还需要继续加强和完善,并提高监测的灵敏性。 Objective To carry out the epidemiological surveillance of acute cerebral meningitis and encephalitis and to establish a sensitive acute meningitis and encephalitis surveillance system, in order to provide reference basis for immunization strategy and laboratory support for clinical diagnosis and treatment. Methods Six hospitals were selected as the sentinel surveillance hospitals in Yichang City for epidemiological survey of acute meningitis and encephalitis cases.Results During 2006-2013, 54.7%(1 385/2 532) of AMES cases were in the urban area.The peak season appeared in May to July. Cases were found mostly in students and famers. 1 313 cases(51.9%) had virus infection and 393 cases(26.9%) were due to bacterial infections. The cases of unknown etiology were 682(26.9%). Conclusion The surveillance and preventive control for AMES surveillance system should be enhanced to improve monitoring sensitivity.
出处 《中国公共卫生管理》 2016年第2期228-230,共3页 Chinese Journal of Public Health Management
基金 湖北省卫生厅科研基金指导性项目(JX3C40)
关键词 急性脑膜炎和脑炎 监测系统 病毒 细菌 免疫 acute meningitis/encephalitis monitoring system viruses bacteria immunization
  • 相关文献

参考文献5

二级参考文献29

  • 1潘晓玲,梁国栋.病毒性脑炎[J].中华实验和临床病毒学杂志,2006,20(3):288-291. 被引量:43
  • 2郭绶衡,肖洁华,李光密.我国1991-2005年流行性乙型脑炎发病与死亡分析[J].中国热带医学,2006,6(12):2137-2139. 被引量:24
  • 3WHO. Recommended standards for surveillance of selected vaccine-preventable diseases[ M]. Geneva: WHO,2003:4 - 10.
  • 4WHO. Manual for the Laboratory Diagnosis of Japanese Encephalitis Virus Infection [ M ]. Geneva : WH0,2007:9 - 13.
  • 5DCPP. Disease Control Priorities in Developing Countries[ M]. 2nd ed, Washington : World Bank,2006:399.
  • 6Robbins JB, Schneerson R, Gotschlich EC, et al. Meningococcal meningitis in sub-Saharan Africa: the case for mass and routine vaccination with available polysaccharide vaccines[J].WHO Epub,2003,81 (10) :745.
  • 7Reefhuis J, Honein MA, Whimey CG. Risk of Bacterial Meningitis in Children with Cochlear Implants[ J]. New England Med,2003,349 ( 5 ) :435.
  • 8Marc PG, Marie-Pierre P, Maria-Teresa A, et al. A review of vaccine research and development: Meningococcal disease[J]. Vaccine ,2006,24 ( 22 ) :4692 - 4700.
  • 9Southem J, Crowley-Luke A, Borrow R, et al. lmmunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants st 2,3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine [J]. Vaccine,2006,24(2) :215 -219.
  • 10Irani DN. Aseptic meningitis and viral myelitis [J]. Neurol Clin, 2008, 26 (3): 635-655.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部